Intravenous Immunoglobulin Therapy in Neurological Diseases During Pregnancy
Authors
Affiliations
Immunological changes during pregnancy influence the course of neurological autoimmune diseases in different ways. In case of pregnancy immunomodulatory standard therapies such as interferon-beta, glatiramer acetate,monoclonal antibodies and cytostatics mostly should be discontinued. In those cases intravenous immunoglobulin (IVIg) therapy might be an alternative. In some diseases, contemporary publications describe positive therapeutic effects on the course of disease during or after pregnancy.
Straubel D, Thielitz A, Reinhold A, Grungreiff K, Reinhold D J Immunol Res. 2018; 2018:5982169.
PMID: 30356433 PMC: 6178489. DOI: 10.1155/2018/5982169.
Fragoso Y, Finkelsztejn A, Kaimen-Maciel D, Grzesiuk A, Gallina A, Lopes J CNS Drugs. 2010; 24(11):969-76.
PMID: 20806993 DOI: 10.2165/11538960-000000000-00000.
Neuroprotection in stroke by complement inhibition and immunoglobulin therapy.
Arumugam T, Woodruff T, Lathia J, Selvaraj P, Mattson M, Taylor S Neuroscience. 2008; 158(3):1074-89.
PMID: 18691639 PMC: 2639633. DOI: 10.1016/j.neuroscience.2008.07.015.